🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Software as a service startup Spry Therapeutics secures $15 million

Economic TimesEconomic Times · 9m ago
Software as a service startup Spry Therapeutics secures $15 million
Medial

- Pune-based software as a service (SaaS) company Spry Therapeutics raises $15 million in funding led by Flourish Ventures and participated by existing investors. - Spry Therapeutics focuses on building software for physical healthcare centers, with a particular emphasis on the US market. - The company has onboarded 105 clinics in the US within 18 months of launch and plans to expand its client base further. - Spry Therapeutics offers integrated software for clinical management, administrative functions, and financial services like insurance claims processing and billing. - The startup will utilize the new funds to establish a sales and servicing team in the US market and strengthen its presence in the physical therapy industry. - Spry Therapeutics leverages India's strong IT talent pool to develop software tailored for the US healthcare market.

5

Related News

Startup funding drops 37% on year to $103 million this week

Economic TimesEconomic Times · 9m ago
Startup funding drops 37% on year to $103 million this week
Medial

- Startups raised $103.2 million in funding between October 5 and October 11, a 36.7% decrease from the same period last year. - This week's funding total of $103.2 million represents a 34.1% increase from the previous week's total of $77 million. - In total, startups secured funds through 21 deals this week, compared to 29 deals during the same period last year. - Haber, an AI-driven robotics startup, raised $38 million in a funding round led by Creaegis, with participation from Accel India and BeeNext Capital. - Spry Therapeutics, a SaaS company, secured $15 million in funding from Flourish Ventures and existing investors. - Economy Process Solutions, a vacuum and process solutions startup, raised $12 million in a series A round led by Stakeboat Capital Fund II.

Exclusive: Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 Cr

EntrackrEntrackr · 1y ago
Exclusive: Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 Cr
Medial

Cancer focused biotech startup Immuneel Therapeutics has raised Rs 100 crore or $12 million in the extension of Series A round from Taiba Middle East FZ LLC. This is the third round of investment for the Bengaluru-based company since its inception in 2018. The board at Immuneel Therapeutic has passed a special resolution to issue 1o equity shares and 8,164 Series A1 CCPS at an issue price of Rs 1,22,330 each to raise Rs 100 crore or $12 million, its regulatory filing accessed from the Registrar of Companies show. The company will use these investments for growth and expansion as decided by the board, the filings further added. As per TheKredible’s estimates, the firm has been valued at around Rs 587 crore or $71 million (post-allotment). Following the fresh proceeds, Taiba Middle East FZ holds a 17% stake in Immuneel Therapeutics. The round appears to be ongoing and it may raise more funds. The company has raised around $40 million to date including its $15 million Series A financing co-led by Eight Roads Ventures, True North, and F-Prime Capital in 2022. Founded by Biocon founder Kiran Mazumdar Shaw, oncologist and Pulitzer winner — Siddhartha Mukherjee and Kush Parwar, Immuneel Therapeutics is an Indian clinical-stage startup which is engaged in developing cell and gene therapies for cancer patients. It’s also working on developing its own pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular immunotherapies for management and treatment of cancer. The firm claims to offer therapies at one-third of the costs borne for gene therapies in America. While the company is yet to file its annual statements for FY24, six-year-old Immuneel Therapeutics remained at a pre-revenue stage in FY23. Its losses stood at Rs 39 crore in the fiscal year ending March 2023.

Download the medial app to read full posts, comements and news.